HCPCS Code C9167

Injection, adamts13, recombinant-krhn, 10 iu
Code effective Jul 01, 2024

HCPCS Section
Temporary Codes for Use with Outpatient Prospective Payment System

C9167 is a valid 2026 HCPCS code meaning Injection, adamts13, recombinant-krhn, 10 iu or (Inj, adzynma, 10 iu) for short. HCPCS C9167 has been effective since 07/01/2024 and applies to Medical care.


HCPCS Code Details - C9167

HCPCS Level II Code
Section C - Temporary Codes for Use with Outpatient Prospective Payment System
HCPCS Code C9167
Description

Long description:
Injection, adamts13, recombinant-krhn, 10 iu

Short description:
Inj, adzynma, 10 iu

HCPCS Pricing indicator 53 - Statute
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Statute number 1833(t)
Coverage code D - Special coverage instructions apply
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jul 01, 2024
Date added Added Apr 01, 2024
Termination date Jun 30, 2024

See also

  • HCPCS C9166 · Injection, secukinumab, intravenous, 1 mg

  • HCPCS J7171 · Injection, adamts13, recombinant-krhn, 10 iu

  • HCPCS C9168 · Injection, mirikizumab-mrkz, 1 mg

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”


HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.